Royal London Asset Management
AGN

Royal London Asset Management’s Allergan Inc AGN Stock Holding History

Royal London Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-88,279
Closed -$13.9M – 589
2014
Q2 		$13.9M Sell
88,279
-946
-1% -$147K 0.32% 77
2014
Q1 		$14.3M Buy
89,225
+17,392
+24% +$2.12M 0.33% 76
2013
Q4 		$8.27M Buy
71,833
+751
+1% +$71.7K 0.21% 117
2013
Q3 		$6.6M Buy
71,082
+780
+1% +$70K 0.18% 133
2013
Q2 		$6M Buy
+70,302
New +$7.29M 0.18% 129

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Royal London Asset Management's AGN Position: Q3 2014 in Review

Royal London Asset Management sold out of Allergan Inc (AGN) in Q3 2014, closing a stake of 88,279 shares — an estimated $13.9M sold.

Royal London Asset Management first reported a position in AGN in Q2 2013 and held it in 5 quarters. The position peaked at $14.3M in Q1 2014. 749 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

  • Royal London Asset Management reported no remaining Allergan Inc position as of Q3 2014 after selling out during the quarter.
  • Royal London Asset Management sold 88,279 Allergan Inc shares in Q3 2014, an estimated $13.9M.
  • Royal London Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 5 quarters.
  • Royal London Asset Management's Allergan Inc position peaked at $14.3M in Q1 2014.
  • 749 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2014.

Based on Royal London Asset Management's 13F filing for Q3 2014, filed 26 Nov 2014.